As a health care Group with more than 300,000 employees, Fresenius plays an important role in society. For more than 100 years, our mission has been to preserve life, promote health and improve patients' quality of life – as defined in our company objective – better medicine for more people.
For Fresenius, economic success is not an end in itself, but a means of continuously investing in medical progress. The patient's well-being always comes first. It is our point of reference for all business decisions. The common goal of all business segments is to improve health care quality and efficiency. In line with our commitment to the future – forward thinking health care to improve the lives of patients – we aim to provide innovative solutions and work proactively to enable a growing number of people to have access to high-quality, affordable medicine. In conclusion, it is our goal to contribute to medical progress.
In our Code of Conduct, we commit to integrity in dealing with our business associates as well as to socially responsible behavior and transparent communication. The Fresenius Code of Conduct defines basic principles that apply to all employees, executives and the management of the Fresenius Group. It also sets out the framework for the relevant regulations of the individual business segments, and defines our respective activity areas. Further information can be found in the section Compliance and Integrity.
We take responsibility for our patients' well-being and are committed to the highest quality in our products, treatments and services.
We want to do the right thing and comply with all applicable rules and laws. In addition to legal requirements, we adhere to high ethical standards and rules of good corporate governance.
We largely owe our success and growth to the commitment of our more than 300,000 employees worldwide. Our aim is therefore to be perceived as an attractive employer to acquire talent, retain employees and allow them to develop their skills further in the long term.
We think and act long-term in our business decisions. It therefore goes without saying that we protect nature as the basis of life and treat resources with care.
We are committed to respecting human rights as defined by international standards, such as the Declaration of Human Rights of the United Nations.
Our value chain
Fresenius has an international distribution network and operates more than 90 production facilities. The largest of these are located in the United States, in China, Germany, Japan and Sweden. In the Fresenius Group, all purchasing processes are coordinated centrally within each business segment. Competence teams bundle the needs, conclude framework contracts, and continuously monitor current market and price trends. In addition, they coordinate the global procurement for individual production sites or clinics and initiate quality and safety controls for raw materials and procurement goods (see Supply Chain). Supply reliability and quality of care play an important role in an environment characterized by ongoing cost-containment pressure from health insurers and price pressure in the markets. We therefore constantly optimize our purchasing processes, standardize procurement materials, identify new sources of supply, and negotiate the best possible prices. Maintaining high flexibility while at the same time meeting our strict quality and safety standards is crucial. A broad portfolio of suppliers reduces potential procurement or raw material shortages in both, the product and service business (see Procurement management).
Our sustainability organization